Anticoagulation Control and Major Adverse Clinical Events in Patients with Operated Valvular Heart Disease with and without Atrial Fibrillation Receiving Vitamin K Antagonists

Autor: Hanis H. Zulkifly, Daniele Pastori, Deirdre A. Lane, Gregory Y. H. Lip

Publikováno v: Zulkifly, H H, Pastori, D, Lane, D A & Lip, G Y H 2023, ' Anticoagulation Control and Major Adverse Clinical Events in Patients with Operated Valvular Heart Disease with and without Atrial Fibrillation Receiving Vitamin K Antagonists ', Journal of Clinical Medicine, vol. 12, no. 3, 1141 . https://doi.org/10.3390/jcm12031141
Journal of Clinical Medicine
Volume 12
Issue 3
Pages: 1141

Background: Good quality anticoagulation among patients with operated valvular heart disease is needed to reduce ischaemic and thromboembolic complications. There is limited evidence regarding factors that affect anticoagulation control in patients i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4776894820ba5b15db3b0a70dd23720d
https://vbn.aau.dk/da/publications/f17c6746-8fd2-4ff7-beab-fed0bfbe31af

Anticoagulation control in different ethnic groups receiving vitamin K antagonist therapy for stroke prevention in atrial fibrillation.

Autor: Zulkifly H; University of Birmingham Institute of Cardiovascular Sciences, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, United Kingdom; Fakulti Farmasi, Universiti Teknologi MARA Kampus Puncak Alam, Selangor, Malaysia., Cheli P; University of Birmingham Institute of Cardiovascular Sciences, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, United Kingdom., Lutchman I; University of Birmingham Institute of Cardiovascular Sciences, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, United Kingdom. Electronic address: ivanalutchman@rcsi.ie., Bai Y; University of Birmingham Institute of Cardiovascular Sciences, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, United Kingdom., Lip GYH; Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool, United Kingdom; Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. Electronic address: Gregory.Lip@liverpool.ac.uk., Lane DA; Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool, United Kingdom; Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. Electronic address: deirdre.lane@liverpool.ac.uk.

Publikováno v: Thrombosis research [Thromb Res] 2020 Aug; Vol. 192, pp. 12-20. Date of Electronic Publication: 2020 May 06.

Epidemiology of atrial fibrillation.

Autor: Zulkifly H; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK., Lip GYH; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK.; Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark., Lane DA; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK.; Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.

Publikováno v: International journal of clinical practice [Int J Clin Pract] 2018 Mar; Vol. 72 (3), pp. e13070. Date of Electronic Publication: 2018 Mar 01.